York Instruments Key Team Members

York Instruments is a new company specializing in magnetic measurements and their healthcare applications. The team we have assembled is comprised of a dynamic mix of industry veterans along with fresh scientific, medical and business professionals.

Gordon Baltzer has over 30 years of experience in the pharmaceutical and healthcare industries. Mr. Baltzer has held a variety of positions in these fields, including Principal and Executive Vice President of River Oaks Imaging and Diagnostic, a private network of multi-modality diagnostic imaging centers in Houston, Texas; Chief Financial Officer and Vice President of Business Development for Royce Laboratories, Inc., a publicly-held pharmaceutical company in Miami, Florida; Director of Financial Planning and Analysis for Apotex, Inc., Canada’s largest producer of generic pharmaceuticals, with head offices in Toronto, Ontario, Canada; and Board Member, Secretary and Treasurer of Methapharm Inc., a privately held brand-name pharmaceutical company with offices in Brantford, Ontario and Coral Springs, Florida.

He also has large public audit experience with BDO and KPMG in Toronto, Canada. He earned his Bachelor of Arts degree from The University of Western Ontario in London, Ontario, Canada and his Chartered Accountant designation from the Canadian Institute of Charted Accountants.

In addition to his role as Chairman and CEO of York Instruments Ltd., Mr. Baltzer serves as Chairman of The MEI Healthcare Group, a privately-held healthcare development company focused on the development, financing and management of diagnostic imaging and radiation therapy facilities in the United States and internationally.

James Petite was the founder of Neuro Systems LLC, a medical equipment manufacturing company that designs, develops, as well as supplies and markets monitoring systems for usage in traumatic brain injury and cerebrovascular disease. He was also a co-founder and President of Novus Monitoring Ltd. UK that was purchased by Integra Neurosciences.

For the last 14 years, Petite has been deeply involved with the clinical and research applications of MEG. Petite was a Research Associate Professor, Psychobiology/Neuroscience Program at Bowdoin College, was head of Clinical Neurophysiology Project Section, Nomos Corporation and was Research Associate, Dept. of Neurology-Neurosurgery, Dartmouth-Hitchcock Medical Center, Dartmouth College.

Other achievements include Research Associate/Head of Neurophysiological Research, Clinical Research Center, University of Virginia Medical School, and Research Associate, Dept. of Neurology, Georgetown University Medical Center.

Gary Green is former director of the York Neuroimaging Centre, and Co-director of the Centre for Hyperpolarization in MRI. He also holds the following designations: Professor of Neuroimaging, Department of Psychology, University of York; Honorary Professor of Human Neuroscience, Hull-York Medical School; and Advisor, MRC Panel for Biomedical Informatics Fellowship selection.

Some of Dr. Green’s research interests include Neuroscience (basic and clinical), dynamics of the brain, and hyperpolarization of spin in organic molecules, mathematics of non-linear dynamic systems, and non-invasive imaging methods and applications (MRI, MEG and EEG). Dr. Green is a Member of The Physiological Society.

Gordon Haid has been involved in the field of magnetoencephalography for over 25 years. After graduating with a first-class degree in physics from the University of British Columbia, Mr. Haid was key to the creation of the first whole-cortex MEG system, primarily performing data analysis, developing critical algorithms and environmental noise cancellation techniques.

He is co-author of numerous technical publications and a seminal patent in the field. After a change in focus to the business side of brain imaging, Mr. Haid has held the positions of Marketing Manager; Director of Marketing & Technical Sales (UK, Europe and the Americas) and Director of Functional Mapping Sales (North America) at various industry-leading companies. He is a member of both the American Clinical MEG Society and the International Society for the Advancement of Clinical MEG.

Chris leads the cutting-edge physics research behind York Instruments new MEG scanner. He obtained his PhD at Royal Holloway College, University of London. His research focused on studying the behaviour of HyQuids and in particular their interactions with other superconducting circuits. After completing his PhD he continued his work as a Post-Doctoral Research Associate at the London Centre for Nanotechnology. He has published papers in the Journal of Condensed Matter Physics and Physical Review B.

Nat brings over 20 years of software development experience to York Instruments having worked on everything from telecoms embedded systems to enterprise scale content management and data mining. He specialises in leading large C and Python projects, taking them through to long term support.

With over 40 year’s electronics engineering experience, Neil’s career has taken him to North America, Japan, Scandinavia and southern Europe, as well as over 4 years working in the Netherlands with ASM Lithography.

Neil returns to his home city to work with York Instruments, drawing on a wealth of electronics design and project management expertise. His credentials include analogue and digital design, high speed digital logic, ISO9001 quality systems and EMC engineering.
Neil achieved Chartered Status in 2014, and is a member of the Institute of Engineering and Technology.

Isabel has worked in product communications for over fifteen years both in the US and UK and worked on a series of launches – hardware, software and service. From project manager to account director within a San Francisco agency, she led accounts with a broad range of tech and healthcare clients including Apple, Livescribe, Plantronics and Intuit. She is now based in York, UK and brings her considerable experience to assist UK start-up companies.

The York Difference

The new MEG is an unprecedented combination of modern sensors, cryogenics, electronics and software. It offers highly improved data quality and accuracy; opens the door to previously unachievable applications; lowers operating cost; and increases versatility.

The York Instruments MEG is more than simply state-of-the-art. Be prepared.